Journal
BREAST CANCER RESEARCH
Volume 10, Issue 6, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/bcr2207
Keywords
-
Categories
Funding
- NIH [CA95004, CA114301, CA1179151]
- US Department of Defense [W81XWH-08-1-0249]
- NATIONAL CANCER INSTITUTE [R01CA095004, R01CA114301] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Eph receptor tyrosine kinase signaling regulates cancer initiation and metastatic progression through multiple mechanisms. Studies of tumor-cell-autonomous effects of Eph receptors demonstrate their dual roles in tumor suppression and tumor promotion. In addition, Eph molecules function in the tumor microenvironment, such as in vascular endothelial cells, influencing the ability of these molecules to promote carcinoma progression and metastasis. The complex nature of Eph receptor signaling and crosstalk with other receptor tyrosine kinases presents a unique challenge and an opportunity to develop therapeutic intervention strategies for targeting breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available